A Message From the Moderator
non small cell lung cancer
Improving DIBH-PBS treatment for NSCLC: reducing delivery time with advanced spot reduction techniques
non small cell lung cancer
Limertinib for EGFR mutation-positive NSCLC treatment
non small cell lung cancer
FL30: an epidermal growth factor kinase inhibitor overcoming T790M and C797S mutations through unique conformational modulation mechanism
non small cell lung cancer
The association between new cancer therapy innovations and financial toxicity
non small cell lung cancer
The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis
non small cell lung cancer
Reliability of [18F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centers
non small cell lung cancer
Development of an artificial intelligence-based precision medicine decision support system for radiogenomics data sets
non small cell lung cancer
Safety and effectiveness of tepotinib in patients with unresectable, advanced or recurrent non-small cell lung cancer with METex14 skipping alterations: post-marketing surveillance in Japan
non small cell lung cancer
The Nrf2-HMOX1 pathway as a therapeutic target for reversing cisplatin resistance in non-small cell lung cancer via inhibiting ferroptosis
non small cell lung cancer
Reliability of [18F]FDG PET/CT for post-treatment surveillance of non-small cell lung cancer: agreement among multiple centers
non small cell lung cancer
Matching-Adjusted Indirect Comparison of Sotorasib Versus Adagrasib in Previously Treated Advanced/Metastatic Non-Small Cell Lung Cancer Harboring KRAS G12C Mutation
non small cell lung cancer
Rapid and specific immunoPET imaging of Nectin-4 in gastric cancer and non-small cell lung cancer using [64Cu]Cu-NOTA-EV-F(ab’)2
non small cell lung cancer
Safety and effectiveness of tepotinib in patients with unresectable, advanced or recurrent non-small cell lung cancer with METex14 skipping alterations: post-marketing surveillance in Japan
non small cell lung cancer
Dermatologic Adverse Event Mitigation and Management Strategies with Amivantamab + Lazertinib Therapy for Advanced Non-Small Cell Lung Cancer: A Vodcast
non small cell lung cancer
Synergistic Interaction of JTE-607 With EGFR-TKIs (Afatinib and Osimertinib) in Non-Small Cell Lung Cancer Cell Lines H1975 and HCC827
non small cell lung cancer
Rechallenge of immune checkpoint inhibitor after local therapy for immune checkpoint inhibitor-resistant non-small cell lung cancer - Hirano
non small cell lung cancer
Chitosan coated ZnO/Tio2/Gd2O3 nano composites for improved rapamycin delivery in non-small cell lung cancer
non small cell lung cancer
Palbociclib- and regorafenib-loaded nanomicelles for the treatment of non-small cell lung cancer: pharmacokinetic and antitumor evaluations
non small cell lung cancer
EGFR inhibitor suppresses tumor growth by blocking lipid uptake and cholesterol synthesis in non-small cell lung cancer
non small cell lung cancer
Innovation Headroom for a Highly Accurate PD-L1 Companion Diagnostic in Non-small Cell Lung Cancer
non small cell lung cancer
Efficacy and safety of limertinib versus gefitinib as first-line treatment for locally advanced or metastatic non-small-cell lung cancer with EGFR-sensitising mutation: a randomised, double-blind, double-dummy, phase 3 trial
non small cell lung cancer
Multidisciplinary tumor boards and surgical intervention improve overall survival in patients with stage iii non-small cell lung cancer: a retrospective cohort study
non small cell lung cancer
A Systematic Review and Meta-Analysis of the Efficacy and Safety of Lazertinib as First-Line Treatment for EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
non small cell lung cancer
Genetic Alterations Affect Immune Contexture of Non-Small Cell Lung Cancer: Ukrainian Study
non small cell lung cancer
